1
项与 BR101 (Byterna therapeutics) 相关的临床试验 / Not yet recruiting临床1期IIT An Open-Label, Single-Arm Clinical Study Evaluating the Safety and Efficacy of BR101 Injection in Patients With Relapsed/Refractory Multiple Myeloma
This study is an open-label, single-arm, dose-escalation and dose-expansion clinical trial designed to evaluate the maximum tolerated dose, safety, pharmacokinetic profile following administration of BR101 injection, and preliminary efficacy in subjects with relapsed or refractory multiple myeloma.
100 项与 BR101 (Byterna therapeutics) 相关的临床结果
100 项与 BR101 (Byterna therapeutics) 相关的转化医学
100 项与 BR101 (Byterna therapeutics) 相关的专利(医药)
100 项与 BR101 (Byterna therapeutics) 相关的药物交易